The company's development strategy is to grow from a regional player into an international pharmaceutical company, Olpha said in its statement.
The rebranding will take place gradually, as the pharmaceutical industry is highly regulated and changes will also be made to the registration certificates of all medicines, which take time due to procedures at the supervisory authorities, the company said.
"As part of its new development strategy, Olpha has already invested tens o...